Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension

Hypertension Research

Volumn 27, Issue 8, 2004, Pages 545-550

  Uchida, Haruhito ^b   Nakamura, Yoshio ^b   Kaihara, Masanobu ^b   Sugimoto, Taro ^b   Norii, Hisanori ^b   Sasaki, Motofumi ^b   Sato, Hajime ^a   Makino, Hirofumi ^b  

^a Himeji Central Hospital   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Angiotensin II type 1 receptor blocker; Ankle brachial pressure index; Arterial wall stiffness; Losartan; Uric acid

Indexed keywords

LOSARTAN; TELMISARTAN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; FEMALE; HOME MONITORING; HOT FLUSH; HUMAN; HYPERTENSION; MALE; PROSPECTIVE STUDY; PULSE WAVE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 5044235079     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.545     Document Type: Article

References (29)

1. Chobanian AV, Bakris GL, Black HR, et al: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
2. Cifkova R, Erdine S, Fagard R, et al: Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003; 21: 1779-1786.
3. Kelly-Hayes M, Wolf PA, Kase CS, Brand FN, McGuirk JM, D'Agostino RB: Temporal patterns of stroke onset: the Framingham Study. Stroke 1995; 26: 1343-1347.
4. Goldberg RJ, Brady P, Muller JE, et al: Time of onset of symptoms of acute myocardial infarction. Am J Cardiol 1990; 66: 140-144.
5. Kamoi K, Miyakoshi M, Soda S, Kaneko S, Nakagawa O: Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients. Diabetes Care 2002; 25: 2218-2223.
6. Hayashi S, Toyoshima H, Tanabe N, Miyanishi K: Daily peaks in the incidence of sudden cardiac death and fatal stroke in Niigata Prefecture. Jpn Circ J 1996; 60: 193-200.
7. London GM, Cohn JN: Prognostic application of arterial stiffness: task forces. Am J Hypertens 2002; 15: 754-758.
8. Safar H, Mourad JJ, Safar M, Blacher J: Aortic pulse wave velocity, an independent marker of cardiovascular risk. Arch Mal Coeur Vaiss 2002; 95: 1215-1218.
9. Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
10. Takami T, Shigemasa M: Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003; 26: 609-614.
11. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
12. Hozawa A, Ohkubo T, Kikuya M, et al: Blood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: the Ohasama study. Hypertens Res 2002; 25: 57-63.
13. Muller JE, Tofler GH, Stone PH: Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79: 733-743.
14. Ohkubo T, Imai Y, Tsuji I, et al: Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16: 971-975.
15. Tsunoda S, Kawano Y, Horio T, Okuda N, Takishita S: Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res 2002; 25: 167-173.
16. Weber MA: The 24-hour blood pressure pattern: does it have implications for morbidity and mortality? Am J Cardiol 2002; 89: 27A-33A.
17. Kario K, Pickering TG, Umeda Y, et al: Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-1406.
18. Mallion J, Siche J, Lacourciere Y: ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens 1999; 13: 657-664.
19. Neutel J, Smith DH: Evaluation of angiotensin II receptor blockers for 24-hour blood pressure control: meta-analysis of a clinical database. J Clin Hypertens (Greenwich) 2003; 5: 58-63.
20. Minami J, Kawano Y, Ishimitsu T, Yoshimi H, Takishita S: Seasonal variations in office, home and 24 h ambulatory blood pressure in patients with essential hypertension. J Hypertens 1996; 14: 1421-1425.
21. Tomiyama H, Yamashina A, Arai T, et al: Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects. Atherosclerosis 2003; 166: 303-309.
22. Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
23. Nakamura U, Iwase M, Nohara S, Kanai H, Ichikawa K, Iida M: Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res 2003; 26: 163-167.
24. Ichihara A, Hayashi M, Ryuzaki M, Handa M, Furukawa T, Saruta T: Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2002; 17: 1513-1517.
25. Mahmud A, Feely J: Effect of angiotensin II receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens 2002; 15: 1092-1095.
26. Schiffrin EL: Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens 2002; 15: 115S-122S.
27. Dahlof B, Zanchetti A, Diez J, et al: Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J Hypertens 2002; 20: 1855-1864.
28. Asmar R, Gosse P, Topouchian J, N'Tela G, Dudley A, Shepherd GL: Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension. J Renin Angiotensin Aldosterone Syst 2002; 3: 176-180.
29. Yusuf S: From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis. Am J Cardiol 2002; 89: 18A-26A.